Edwards Lifesciences (EW)
Competitors to Edwards Lifesciences (EW)
Abbott Laboratories ABT +0.00
Abbott Laboratories competes with Edwards Lifesciences in the cardiovascular market by providing a diverse range of heart valves, monitoring devices, and diagnostic products. Abbott's extensive experience in both heart and vascular solutions enables it to offer innovative products that appeal to health care providers. Abbott's competitive advantage lies in its strong global distribution network and significant investment in research and development, which allows it to stay ahead in product innovation and technological advancements.
Boston Scientific BSX +0.00
Boston Scientific is a strong contender in the cardiovascular device market, particularly known for its innovations in stents and other interventional products. While Edwards Lifesciences specializes in heart valves and critical care monitoring, Boston Scientific competes by offering a more diversified portfolio that includes devices for arrhythmias and peripheral interventions. The breadth of Boston Scientific's product offerings and their ability to provide comprehensive solutions for various medical conditions gives them a competitive edge in certain aspects of cardiac care.
Medtronic MDT +0.00
Medtronic is one of the largest medical technology companies in the world, offering a wide range of products and therapies that rival those of Edwards Lifesciences, particularly in the areas of heart valve and vascular therapies. Both companies focus on innovative cardiac care, but Medtronic has a broader portfolio that includes device-based therapies for various medical conditions beyond just heart issues. The extensive R&D capabilities and established market presence of Medtronic give it a competitive advantage, allowing it to invest heavily in new technologies and capture larger market shares.
Sorin Group (part of LivaNova)
Sorin Group, now part of LivaNova, specializes in cardiac surgery and offers products that can often overlap with Edwards Lifesciences' heart valve offerings. While Sorin's focus is on cardiac surgery devices and therapies, their entry into the minimally invasive valve market creates competition in areas where Edwards has strong market positioning. However, LivaNova's relative size and resources compared to Edwards result in a more niche competitive dynamic, with Edwards often maintaining a leading edge in innovation and market share.